General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-12 | 2024-09 | -0.66 | N/A | N/A | N/A |
2024-08-09 | 2024-06 | -1.41 | -1.41 | N/A | N/A |
2024-05-14 | 2024-03 | -0.3 | -0.7 | -0.4 | -133.33% |
2024-05-14 | 2024-03 | -0.3 | N/A | N/A | N/A |
2024-03-27 | 2023-12 | 0.1 | -0.3 | -0.4 | -400.00% |
2024-03-27 | 2023-12 | 0.1 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-12-25 | BECHER CHARLES | Officer | 233.23K | Conversion of Exercise of derivative security |
2024-07-18 | CASSANO JAMES S. | Director | 25.78K | Sale |
2023-09-14 | CROLIUS CLAYTON | Chief Financial Officer | 86.70K | Purchase |
2023-03-23 | HOWE ALAN BRADLEY | Director | 176.40K | Purchase |
2023-08-22 | LIU HAO PETER | Chief Executive Officer | 2.06M | Conversion of Exercise of derivative security |
2024-06-20 | MULICA MICHAEL C | Director | 428.16K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | EAM Investors, LLC | 1.02M | 1.17M | 2.47% |
2023-06-29 | Vanguard Group Inc | 296.03K | 340.44K | 0.72% |
2023-06-29 | Sicart Associates LLC | 221.00K | 254.15K | 0.54% |
2023-06-29 | Bank Of New York Mellon Corporation | 215.94K | 248.33K | 0.52% |
2023-06-29 | Geode Capital Management, LLC | 167.42K | 192.53K | 0.41% |
2023-06-29 | Renaissance Technologies, LLC | 77.23K | 88.82K | 0.19% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 239.93K | 275.91K | 0.58% |
2023-08-30 | iShares Micro Cap ETF | 62.34K | 42.02K | 0.15% |
2023-06-29 | Vanguard Extended Market Index Fund | 56.11K | 64.52K | 0.14% |
2023-05-30 | Fidelity Extended Market Index Fund | 43.60K | 44.91K | 0.11% |
2023-05-30 | Fidelity Total Market Index Fund | 33.24K | 34.23K | 0.08% |
2023-05-30 | Fidelity Series Total Market Index Fund | 12.50K | 12.88K | 0.03% |
Split | Date |
---|---|
1 : 10 | 2024-07-18 |
1 : 10 | 2021-09-16 |
EBS
Walgreens is taking an important step to increase access to and education around naloxone by announcing that over-the-counter (OTC) NARCAN Nasal Spray will be available at Walgreens stores and online as soon as Sept. 5, with nationwide availability on Sept. 7. This announcement follows the U.S. Food and Drug Administration's (FDA) approval earlier this year.
This press release features multimedia. View the full release here:
So hilarious seeing these posts by bears telling you to sell fake profits lol that’s how u know there worried lol
Strong supports at 1.30
Added 1k more not selling at this price fuk that!!
Don’t let them shake you buy the dip!!!
Hold we testing $2 today next week 3-5
Look at those big green bar candles!! Woohoo LFG!! BUY
Get in before $2!!!
LFG this is so cheap!! Buy as much as you can!!
Hold $3-5 soon!!
We traded the entire float today this will rip HOLD strong!!!
We traded the entire float today this will rip HOLD strong!!!
Added 2500 today LFG !!
Slap that assssssk LFG!!
$2 Afterhours!!!
Let’s run buy it up!!!!
Look like a Green Day
$SONM pt $3.64-$5.18+++ st